Shorter blood thinner course may be safe for new moms with clotting gene mutations
NCT ID NCT07342127
First seen Jan 23, 2026 · Last updated May 09, 2026 · Updated 19 times
Summary
This study looked at how long women with Factor V Leiden or Factor II mutations should take blood thinners after giving birth to prevent dangerous blood clots. Researchers compared treatment lasting less than 2 weeks versus 6 weeks in 86 women. The goal was to see if shorter treatment still prevents clots while causing fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service Gynécologie Obstétrique - Hôpital de la Croix Rousse
Lyon, 69004, France
-
Service d'hémostase clinique - Hôpital Louis Pradel
Bron, 69500, France
Conditions
Explore the condition pages connected to this study.